Anatomic pathology specialty in medicine deals with the recognition of various diseases on the basis of the microscopic, macroscopic, biochemical, molecular inspection of organs and tissues and immunological fields. Medical professionals practice anatomical as well as clinical pathology.
Anatomic pathology deals with the processing, examination, and diagnosis of surgical specimens that are done by a physician who is trained in pathological diagnosis. They are two forms of pathology i.e.:
1) Anatomic Pathology 2) Clinical Pathology
Clinical pathology processes the test requests which are more familiar to the general public like blood cell counts, urinalysis, blood glucose level determinations coagulation studies, and throat cultures. Pathology subsections include hematology, immunology, microbiology, urinalysis, chemistry, and blood bank.
Anatomical pathology is divided into various subspecialties that are used in surgical pathology like breast, endocrine, gastrointestinal, head and neck, gynecological, soft tissue, GU, dermatopathology, cytopathology, forensic pathology, neuropathology, and hematopathology..
Anatomic pathologies are usually performed in hospitals for investigating the effects of disease on the human body through autopsies and microscopic examination of cells, tissues, and other specimens as well. Medical laboratory administers are in charge of the sophisticated laboratory tests on samples of tissues or fluids and the accuracy and quality of the tests. The practice of pathology is conducted in community hospitals and in academic medical centers where patient care, diagnostic services, and research are used simultaneously.
COVID-19 scenario analysis:
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.
Owing to such factors, COVID 19 is expected to have a significant impact on the Anatomic pathology market.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
High incidences of cancer and other diseases, reimbursement availability growing focus on personalized medicine, are the major factors influencing the anatomic pathology market. Moreover, easy access to advanced technologies, government policies and initiatives for screening cancer patients, increasing investment and expenditure on healthcare, and the presence of high-quality infrastructure for hospitals and clinical laboratories are also helping to grow the market.
On the other hand, the availability of duplicate and inactive products, the lack of skilled professionals in the sector, and product recalls by the manufacturers are expected to hamper the market.
New product launches to flourish the market:
On September 23rd, 2018, Sakura Finetek launched the Accu-Cut SRM 300 LT Manual Microtome which illuminates microtomy.
In the year 2018, F. Hoffmann-La Roche Diagnostics Ltd. Got CE approval for its BenchMark product ULTRA Plus Staining System.
On March 7th, 2016, BD received FDA approval for its new automatic cervical cancer screening systems, BD TotalysMultiProcessor and BD TotalysSlidePrep instruments
Surge in usage in pharmaceutical and biotechnological applications:
Hospital laboratories, clinical laboratories, are the major end-users for the anatomic pathology market. Amongst them, hospital laboratories are the biggest consumers for the same. An increase in the number of patients visiting the hospitals, a rising number of in-house diagnostic procedures that are performed at the hospitals, availability of reimbursements in the markets for clinical tests performed in hospitals are creating the demand for the anatomic pathology market.
Key benefits of the report:
- This study presents the analytical depiction of the global Anatomic pathology industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Anatomic pathology market share.
- The current market is quantitatively analyzed to highlight the global Anatomic pathology market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global Anatomic pathology market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Anatomic pathology Market research report:
- What are the leading market players active in the Anatomic pathology market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Anatomic Pathology Market Report Highlights
| Aspects | Details |
 By Product and Services |
|
 By Application |
|
 By End Users |
|
 By Region |
|
 Key Market Players | Becton, Dickinson and Company, Agilent Technologies, Danaher Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd, Hologic, Inc, Bio SB, BioGenex Laboratories., Thermo Fisher Scientific Inc., DiapathS.p.A., Sakura Finetek |
Loading Table Of Content...
